focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,756.00
Bid: 1,753.00
Ask: 1,754.00
Change: -19.00 (-1.07%)
Spread: 1.00 (0.057%)
Open: 1,770.00
High: 1,770.00
Low: 1,740.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up UPDATE

Tue, 12th Nov 2013 09:20

Accesso: Canaccord Genuity raises target price from 680p to 770p and keeps a buy recommendation.Andor Technology: FinnCap places both its target price (prev.: 390p) and its hold recommendation under review.Babcock International: Jefferies increases target price from 1250p to 1600p retaining a buy recommendation. Investec places its target price (prev.: 1175p) under review, while keeping its add rating.Balfour Beatty: UBS raises target price from 220p to 245p, while downgrading from neutral to sell.British Sky Broadcasting: Alphavalue shifts target price from 1055.2p to 1056.7p and upgrades from add to buy. Credit Suisse reduces target price from 810p to 700p downgrading to underperform.BTG: Investec places its target price (prev.: 472p) under review, while its buy recommendation is kept.Catlin Group: Canaccord Genuity moves target price from 540p to 550p and maintains a buy recommendation.Central Asia Materials: FinnCap initiates with a target price of 222p and a buy recommendation. Canaccord Genuity takes target price from 210p to 245p and stays with its buy recommendation.Chesnara: Canaccord Genuity moves target price from 290p to 300p, while downgrading from buy to hold.Cobham: Deutsche Bank lowers target price from 275p to 270p and maintains a hold recommendation. JP Morgan cuts target price from 310p to 270p reiterating a neutral rating. UBS lowers target price from 305p to 290p leaving its buy recommendation unchanged.Coca-Cola HBC: Goldman Sachs reduces target price from 2100p to 2000p and retains a neutral rating.Craneware: Investec raises target price from 365p to 530p and maintains a buy recommendation.Cropper (James): Westhouse Securities increases target price from 350p to 450p, while downgrading to add.F&C Asset Management: Barclays initiates with a target price of 90p and an underweight rating.GlaxoSmithKline: Panmure Gordon reduces target price from 1850p to 1750p and downgrades from buy to hold.Halfords Group: Deutsche Bank raises target price from 330p to 410p, but still recommends selling.Hunting: FinnCap cuts target price from 900p to 840p, while its hold recommendation is kept.Inmarsat: Alphavalue shifts target price from 729.7p to 732.6p upgrading from reduce to add.Ithaca Energy: Liberum Capital moves target price from 210p to 207p, while staying with its buy recommendation.Lonmin: Deutsche Bank increases target price from 315p to 390p and stays with its hold recommendation. Citi ups target price from 420p to 453p and reiterates a buy recommendation. HSBC raises target price from 485p to 512p leaving its overweight rating unaltered. JP Morgan takes target price from 400p to 430p and keeps an overweight rating.Morgan Advanced Materials: Jefferies lowers target price from 345p to 340p staying with its buy recommendation. JP Morgan moves target price from 335p to 330p, while leaving its overweight rating unchanged. Investec reduces target price from 410p to 390p, while its buy recommendation remains unchanged.Rentokil: Jefferies raises target price from 104p to 116p and keeps a hold recommendation.Rightmove: Panmure Gordon takes target price from 3000p to 3130p maintaining a buy recommendation.Royal Bank of Scotland: Nomura ups target price from 270p to 285p maintaining a reduce rating.RSA Insurance Group: Deutsche Bank shifts target price from 117p to 115p and retains a hold recommendation. Nomura lowers target price fromk 120p to 113p reiterating a neutral rating. JP Morgan cuts target price from 140p to 126p and downgrades to neutral.Shire: Societe Generale increases target price from 3270p to 3615p reiterating a buy recommendation.Smith (WH): Deutsche Bank raises target price from 960p to 1075p maintaining a buy recommendation. UBS increases target price from 750p to 1000p.Speedy Hire: Panmure Gordon shifts target price from 73.6p to 75p and stays with its hold recommendation.Synergy Health: Investec moves target price from 1140p to 1165p and reiterates a buy recommendation.Trifast: N+1 Singer ups target price from 68p to 89p and leaves its buy recommendation unchanged. FinnCap takes target price from 66p to 91p retaining a buy recommendation. Westhouse Securities places both its target price (prev.: 80p) and its buy recommendation under review.Vodafone Group: Espirito Santo ups target price from 215p to 230p and retains a neutral rating.Workspace Group: Liberum Capital takes target price from 546p to 584p and maintains a buy recommendation. Investec ups target price from 500p to 560p retaining a buy recommendation.
More News
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more
20 Feb 2024 08:55

IN BRIEF: Diageo welcomes GSK's CFO as non-executive director

Diageo PLC - London-based brewer and distiller sells more than 200 drinks brands, including Guinness stout, Captain Morgan rum and Johnnie Walker whisky - Appoints GSK PLC's chief financial officer and executive director, Julie Brown, as a non-executive director. Says she will succeed Alan Stewart as chair of the audit committee after his retirement following the firm's annual general meeting in September. Chair Javier Ferran says: "Julie brings many years of experience in financial, commercial and strategic roles in international companies operating in highly regulated industries. She is strongly committed to enabling diversity in business and to creating sustainable, long-term value for stakeholders. I look forward to her contribution to Board discussions and to working with her in progressing Diageo's ambition to be one of the most trusted and respected consumer products companies in the world."

Read more
15 Feb 2024 14:44

UK dividends calendar - next 7 days

Friday 16 February 
JPMorgan Asia Growth & Income PLCdividend payment date
JPMorgan Japan Small Cap Growth & Income PLCdividend payment date
Murray International Trust PLCdividend payment date
Premier Miton Group PLCdividend payment date
Schroder Oriental Income Funddividend payment date
Solid State PLCdividend payment date
Monday 19 February 
no events scheduled 
Tuesday 20 February 
Invesco Bond Income Plus Ltd 
Wednesday 21 February 
no events scheduled 
Thursday 22 February 
abrdn Asia Focus PLCex-dividend payment date
Alumasc Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
BlackRock Throgmorton Trust PLCex-dividend payment date
Braemar PLCex-dividend payment date
easyJet PLCex-dividend payment date
Ecofin US Renewables Infrastructure Trust PLCex-dividend payment date
Endeavour Mining PLCex-dividend payment date
FRP Advisory Group PLCex-dividend payment date
Gateley Holdings PLCex-dividend payment date
GSK PLCex-dividend payment date
Hercules Site Services PLCex-dividend payment date
Jersey Electricity PLCex-dividend payment date
Land Securities Group PLCex-dividend payment date
Molten Ventures VCT PLCex-dividend payment date
Northern Bear PLCex-dividend payment date
Redrow PLCex-dividend payment date
Samuel Heath & Sons PLCex-dividend payment date
Titon Holdings PLCex-dividend payment date
Unilever PLCex-dividend payment date
Van Elle Holdings PLCex-dividend payment date
Virgin Money UK PLCex-dividend payment date
Witan Investment Trust PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
15 Feb 2024 11:02

Berenberg hikes target price on GSK

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker GSK from £16.50 to £18.20 on Thursday, stating the group was moving closer to offsetting losses associated with the expiry of its patent on HIV drug dolutegravir.

Read more
15 Feb 2024 09:45

LONDON BROKER RATINGS: Jefferies cuts Kingfisher but Citi raises

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
15 Feb 2024 08:49

GSK completes USD1.4 billion purchase of respiratory firm Aiolos Bio

(Alliance News) - GSK PLC on Thursday said it has completed the acquisition of Aiolos Bio Ltd, expanding its respiratory portfolio with a potential "best-in-class" asthma treatment.

Read more
13 Feb 2024 16:53

LONDON MARKET CLOSE: Stocks in red amid sticky US inflation data

(Alliance News) - Stock prices in London closed in the red on Tuesday, after a key US inflation reading came in hotter-than-expected.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.